Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

March 01, 2014; Volume 85,Issue 3

Minireviews

  • You have access
    Activators of G Protein Signaling Exhibit Broad Functionality and Define a Distinct Core Signaling Triad
    Joe B. Blumer and Stephen M. Lanier
    Molecular Pharmacology March 2014, 85 (3) 388-396; DOI: https://doi.org/10.1124/mol.113.090068

Articles

  • You have access
    Recovery of Current through Mutated TASK3 Potassium Channels Underlying Birk Barel Syndrome
    Emma L. Veale, Mustafa Hassan, Yvonne Walsh, Ehab Al-Moubarak and Alistair Mathie
    Molecular Pharmacology March 2014, 85 (3) 397-407; DOI: https://doi.org/10.1124/mol.113.090530
  • You have access
    Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells
    Laurence Booth, Jane L. Roberts, Nichola Cruickshanks, Adam Conley, David E. Durrant, Anindita Das, Paul B. Fisher, Rakesh C. Kukreja, Steven Grant, Andrew Poklepovic and Paul Dent
    Molecular Pharmacology March 2014, 85 (3) 408-419; DOI: https://doi.org/10.1124/mol.113.090043
  • You have access
    Pore-Exposed Tyrosine Residues of P-Glycoprotein Are Important Hydrogen-Bonding Partners for Drugs
    Yaprak Dönmez Cakil, Narakorn Khunweeraphong, Zahida Parveen, Diethart Schmid, Matthias Artaker, Gerhard F. Ecker, Harald H. Sitte, Oliver Pusch, Thomas Stockner and Peter Chiba
    Molecular Pharmacology March 2014, 85 (3) 420-428; DOI: https://doi.org/10.1124/mol.113.088526
  • You have access
    Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy In Vivo
    Marc Lamphier, Wanjun Zheng, Eicke Latz, Mark Spyvee, Hans Hansen, Jeffrey Rose, Melinda Genest, Hua Yang, Christina Shaffer, Yan Zhao, Yongchun Shen, Carrie Liu, Diana Liu, Thorsten R. Mempel, Christopher Rowbottom, Jesse Chow, Natalie C. Twine, Melvin Yu, Fabian Gusovsky and Sally T. Ishizaka
    Molecular Pharmacology March 2014, 85 (3) 429-440; DOI: https://doi.org/10.1124/mol.113.089821
  • You have access
    cdc-Like/Dual-Specificity Tyrosine Phosphorylation–Regulated Kinases Inhibitor Leucettine L41 Induces mTOR-Dependent Autophagy: Implication for Alzheimer’s Disease
    Xavier Fant, Emilie Durieu, Gaëtan Chicanne, Bernard Payrastre, Diego Sbrissa, Assia Shisheva, Emmanuelle Limanton, François Carreaux, Jean-Pierre Bazureau and Laurent Meijer
    Molecular Pharmacology March 2014, 85 (3) 441-450; DOI: https://doi.org/10.1124/mol.113.090837
  • You have access
    Triapine and a More Potent Dimethyl Derivative Induce Endoplasmic Reticulum Stress in Cancer Cells
    Robert Trondl, Lea S. Flocke, Christian R. Kowol, Petra Heffeter, Ute Jungwirth, Georg E. Mair, Ralf Steinborn, Éva A. Enyedy, Michael A. Jakupec, Walter Berger and Bernhard K. Keppler
    Molecular Pharmacology March 2014, 85 (3) 451-459; DOI: https://doi.org/10.1124/mol.113.090605
  • You have access
    5′-AMP-Activated Protein Kinase Attenuates Adriamycin-Induced Oxidative Podocyte Injury through Thioredoxin-Mediated Suppression of the Apoptosis Signal-Regulating Kinase 1–P38 Signaling Pathway
    Kun Gao, Yuan Chi, Wei Sun, Masayuki Takeda and Jian Yao
    Molecular Pharmacology March 2014, 85 (3) 460-471; DOI: https://doi.org/10.1124/mol.113.089458
  • You have access
    Regulation of β2-Adrenergic Receptor Function by Conformationally Selective Single-Domain Intrabodies
    Dean P. Staus, Laura M. Wingler, Ryan T. Strachan, Soren G. F. Rasmussen, Els Pardon, Seungkirl Ahn, Jan Steyaert, Brian K. Kobilka and Robert J. Lefkowitz
    Molecular Pharmacology March 2014, 85 (3) 472-481; DOI: https://doi.org/10.1124/mol.113.089516
  • You have access
    Differential Roles of Ubiquitination in the Degradation Mechanism of Cell Surface–Resident Bile Salt Export Pump and Multidrug Resistance–Associated Protein 2
    Kensuke Aida, Hisamitsu Hayashi, Kaori Inamura, Tadahaya Mizuno and Yuichi Sugiyama
    Molecular Pharmacology March 2014, 85 (3) 482-491; DOI: https://doi.org/10.1124/mol.113.091090
  • You have access
    Quantification of Ligand Bias for Clinically Relevant β2-Adrenergic Receptor Ligands: Implications for Drug Taxonomy
    Emma T. van der Westhuizen, Billy Breton, Arthur Christopoulos and Michel Bouvier
    Molecular Pharmacology March 2014, 85 (3) 492-509; DOI: https://doi.org/10.1124/mol.113.088880
  • You have access
    Mutation of Cys242 of Human Monoacylglycerol Lipase Disrupts Balanced Hydrolysis of 1- and 2-Monoacylglycerols and Selectively Impairs Inhibitor Potency
    Tuomo Laitinen, Dina Navia-Paldanius, Roosa Rytilahti, Joona J. T. Marjamaa, Julie Kařízková, Teija Parkkari, Tatu Pantsar, Antti Poso, Jarmo T. Laitinen and Juha R. Savinainen
    Molecular Pharmacology March 2014, 85 (3) 510-519; DOI: https://doi.org/10.1124/mol.113.090795
  • You have access
    Bcrp1;Mdr1a/b;Mrp2 Combination Knockout Mice: Altered Disposition of the Dietary Carcinogen PhIP (2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]Pyridine) and Its Genotoxic Metabolites
    Maria L. H. Vlaming, Sebastiaan F. Teunissen, Evita van de Steeg, Anita van Esch, Els Wagenaar, Luc Brunsveld, Tom F. A. de Greef, Hilde Rosing, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
    Molecular Pharmacology March 2014, 85 (3) 520-530; DOI: https://doi.org/10.1124/mol.113.088823

Erratum

  • You have access
    Correction to “The Phosphoinositide-Dependent Kinase-1 Inhibitor 2-Amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) Prevents Y-Box Binding Protein-1 from Inducing Epidermal Growth Factor Receptor”
    Molecular Pharmacology March 2014, 85 (3) 531-532; DOI: https://doi.org/10.1124/mol.114.85er03
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 85 (3)
Molecular Pharmacology
Vol. 85, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Minireviews
  • Articles
  • Erratum
  • Most Read
Loading
  • Proteomic Analysis of GPCR Cell Biology
  • Phosphoproteomic Analysis of cAMP-Dependent Pathways
  • Phosphoproteomic Identification of Signaling Pathways
  • How Many G Protein-Coupled Receptors are Drug Targets?
  • Wnt Signaling and Drug Resistance in Cancer
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics